“Nothing is more powerful than an idea whose time has come!” – Victor Hugo

Immediate Sequential Bilateral Cataract Surgery (ISBCS) isn’t new – it was topical when Jacques Daviel invented cataract extraction in 1752. But it’s still a subject of discussion in 2017. Why? Cataract hasn’t really changed; it’s still predominantly a bilateral disease. Patients haven’t really changed either, and they still question why a bilateral disease needs separate episodes of care. In repeated surveys, around eight in every 10 of patients would prefer ISBCS. This is because they want rapid visual rehabilitation (days rather than weeks or months), reduced costs for travel and spectacles, and reduced payments if they’re funding the treatment themselves. What’s not to like? Unfortunately, surgeons haven’t really changed their views on the subject, with many not reviewing the evidence for years. This often means their objections haven’t changed in over a decade! Predictably, the concerns include the risk of infection, toxic anterior segment syndrome (TASS), corneal or retinal edema, and refractive surprise…